218 related articles for article (PubMed ID: 17389142)
1. The acid-sensitive potassium channel TASK-1 in rat cardiac muscle.
Putzke C; Wemhöner K; Sachse FB; Rinné S; Schlichthörl G; Li XT; Jaé L; Eckhardt I; Wischmeyer E; Wulf H; Preisig-Müller R; Daut J; Decher N
Cardiovasc Res; 2007 Jul; 75(1):59-68. PubMed ID: 17389142
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
[TBL] [Abstract][Full Text] [Related]
3. The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle.
Xian Tao Li ; Dyachenko V; Zuzarte M; Putzke C; Preisig-Müller R; Isenberg G; Daut J
Cardiovasc Res; 2006 Jan; 69(1):86-97. PubMed ID: 16248991
[TBL] [Abstract][Full Text] [Related]
4. TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II.
Czirják G; Fischer T; Spät A; Lesage F; Enyedi P
Mol Endocrinol; 2000 Jun; 14(6):863-74. PubMed ID: 10847588
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of the potassium channel TASK-1 in rat cardiac muscle by endothelin-1 is mediated by phospholipase C.
Schiekel J; Lindner M; Hetzel A; Wemhöner K; Renigunta V; Schlichthörl G; Decher N; Oliver D; Daut J
Cardiovasc Res; 2013 Jan; 97(1):97-105. PubMed ID: 22977011
[TBL] [Abstract][Full Text] [Related]
6. TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.
Rinné S; Kiper AK; Schlichthörl G; Dittmann S; Netter MF; Limberg SH; Silbernagel N; Zuzarte M; Moosdorf R; Wulf H; Schulze-Bahr E; Rolfes C; Decher N
J Mol Cell Cardiol; 2015 Apr; 81():71-80. PubMed ID: 25655935
[TBL] [Abstract][Full Text] [Related]
7. Identification of the A293 (AVE1231) Binding Site in the Cardiac Two-Pore-Domain Potassium Channel TASK-1: a Common Low Affinity Antiarrhythmic Drug Binding Site.
Wiedmann F; Kiper AK; Bedoya M; Ratte A; Rinné S; Kraft M; Waibel M; Anad P; Wenzel W; González W; Katus HA; Decher N; Schmidt C
Cell Physiol Biochem; 2019; 52(5):1223-1235. PubMed ID: 31001961
[TBL] [Abstract][Full Text] [Related]
8. alpha 1-Adrenoceptor stimulation partially inhibits ATP-sensitive K+ current in guinea pig ventricular cells: attenuation of the action potential shortening induced by hypoxia and K+ channel openers.
Takizawa T; Hara Y; Saito T; Masuda Y; Nakaya H
J Cardiovasc Pharmacol; 1996 Dec; 28(6):799-808. PubMed ID: 8961078
[TBL] [Abstract][Full Text] [Related]
9. Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex.
Decher N; Wemhöner K; Rinné S; Netter MF; Zuzarte M; Aller MI; Kaufmann SG; Li XT; Meuth SG; Daut J; Sachse FB; Maier SK
Cell Physiol Biochem; 2011; 28(1):77-86. PubMed ID: 21865850
[TBL] [Abstract][Full Text] [Related]
10. Both alpha(1A)- and alpha(1B)-adrenergic receptor subtypes couple to the transient outward current (I(To)) in rat ventricular myocytes.
Homma N; Hirasawa A; Shibata K; Hashimito K; Tsujimoto G
Br J Pharmacol; 2000 Mar; 129(6):1113-20. PubMed ID: 10725259
[TBL] [Abstract][Full Text] [Related]
11. TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells.
Czirják G; Enyedi P
Mol Endocrinol; 2002 Mar; 16(3):621-9. PubMed ID: 11875121
[TBL] [Abstract][Full Text] [Related]
12. KT3.2 and KT3.3, two novel human two-pore K(+) channels closely related to TASK-1.
Vega-Saenz de Miera E; Lau DH; Zhadina M; Pountney D; Coetzee WA; Rudy B
J Neurophysiol; 2001 Jul; 86(1):130-42. PubMed ID: 11431495
[TBL] [Abstract][Full Text] [Related]
13. Identification of the muscarinic pathway underlying cessation of sleep-related burst activity in rat thalamocortical relay neurons.
Bista P; Meuth SG; Kanyshkova T; Cerina M; Pawlowski M; Ehling P; Landgraf P; Borsotto M; Heurteaux C; Pape HC; Baukrowitz T; Budde T
Pflugers Arch; 2012 Jan; 463(1):89-102. PubMed ID: 22083644
[TBL] [Abstract][Full Text] [Related]
14. pH-dependent inhibition of K₂P3.1 prolongs atrial refractoriness in whole hearts.
Skarsfeldt MA; Jepps TA; Bomholtz SH; Abildgaard L; Sørensen US; Gregers E; Svendsen JH; Diness JG; Grunnet M; Schmitt N; Olesen SP; Bentzen BH
Pflugers Arch; 2016 Apr; 468(4):643-54. PubMed ID: 26729267
[TBL] [Abstract][Full Text] [Related]
15. Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels.
Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1003-16. PubMed ID: 22790794
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
17. The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone.
Gierten J; Ficker E; Bloehs R; Schweizer PA; Zitron E; Scholz E; Karle C; Katus HA; Thomas D
Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):261-70. PubMed ID: 19777211
[TBL] [Abstract][Full Text] [Related]
18. The potassium current carried by TREK-1 channels in rat cardiac ventricular muscle.
Bodnár M; Schlichthörl G; Daut J
Pflugers Arch; 2015 May; 467(5):1069-79. PubMed ID: 25539776
[TBL] [Abstract][Full Text] [Related]
19. TASK-like K+ channels mediate effects of 5-HT and extracellular pH in rat dorsal vagal neurones in vitro.
Hopwood SE; Trapp S
J Physiol; 2005 Oct; 568(Pt 1):145-54. PubMed ID: 16020457
[TBL] [Abstract][Full Text] [Related]
20. Methoxamine inhibits transient outward potassium current through alpha1A-adrenoceptors in rat ventricular myocytes.
Martínez ML; Delgado C
J Cardiovasc Pharmacol; 2000 Feb; 35(2):212-8. PubMed ID: 10672852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
